FDA: Singulair to Get ‘Black Box’ Warning
Drug has long carried warning of potentially dangerous neuropsychiatric side effects
Gulf War Illness Still Poses High Symptom Burden
Vast majority of diagnosed veterans report fatigue, sleep, and pain symptoms
Short-Term Medications May Cut Risk for ‘Broken Heart’ Syndrome
Combination of low-dose β-blocker and aspirin may reduce heightened CV risk in early bereavement
Considerable Increase Seen in List, Net Prices of Branded Drugs
From 2007 to 2018, list prices increased 159 percent, while net prices increased by 60 percent
Racial/Ethnic Insurance Coverage Disparity Down Since ACA
From 2013 to 2017, drop seen in unadjusted, adjusted black-white gap, Hispanic-white gap in uninsurance
FDA Bans Electrical Shock Devices Used on the Mentally Disabled
Ban takes effect 30 days after publication in the Federal Register
CDC: ~14 Percent of Children Have ADHD, Learning Disability
Likelihood of having ever been diagnosed with ADHD, learning disability highest for non-Hispanic blacks
NICU Babies at Risk for Later Mental Health Issues
Findings based on long-term follow-up of NICU graduates into adolescence
Evidence Lacking for Pharmacologic Therapy for Cannabis Use Disorder
Several drug classes including cannabinoids, SSRIs seem to be ineffective for cannabis use disorder
1996 to 2016 Saw Increases in U.S. Spending on Health Care
Public, private insurance, out-of-pocket payments increased by 2.9, 2.6, and 1.1 percent annually
